Form 4 for ACAD ACADIA PHARMACEUTICALS INC
Accepted 2022-10-18 00:00:00 ET · period of report 2022-10-15 · accession 0001209191-22-054026 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-10-18 | 2022-10-15 | ACAD | DAVIS STEPHEN | CEO, Dir | S - Sale+OE | $15.81 | -2,804 | 79.0K | -3% | -$44.3K |
| D | 2022-10-18 | 2022-10-15 | ACAD | DAVIS STEPHEN | CEO, Dir | M - OptEx | — | +5,938 | 81.8K | +8% | — |
| D | 2022-10-18 | 2022-10-15 | ACAD | DAVIS STEPHEN | CEO, Dir | M - OptEx | $0.00 | -5,938 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-15 | S | D | 2,804 | $15.81 | 79,009 | D | — | — | |
| 2 | Common | Common Stock | 2022-10-15 | M | A | 5,938 | — | 81,813 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. |
| 3 | Derivative | Restricted Stock Units | 2022-10-15 | M | D | 5,938 | $0.00 | 0 | D | — · — to — | 5,938 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. (F3) The restricted stock units vest in four equal annual installments beginning 10/15/19. |